MicroRNAs (miRNAs) are endogenous small noncoding RNAs that regulate gene expression by either degrading or inhibiting the translation of mRNAs and have significant roles in the development of various tumors. A polymorphism (rs2682818) in miR-618 has been confirmed to be correlated with susceptibility to various cancers. Nonetheless, its role has not been investigated in neuroblastoma to date. Therefore, we assessed whether the miR-618 rs2682818 C>A polymorphism was correlated with neuroblastoma risk in the Chinese population.

Colorectal cancer (CRC) ranks third in incidence and second in mortality worldwide. In Ecuador, there are 2,481 new CRC cases per year and 2,366 cancer deaths yearly. CRC presents in stages III-IV in more than 50% of patients. The standard treatment for CRC is chemotherapy, with an overall survival (OS) of 29–31 months. The status of biomarkers KRAS, NRAS, BRAF, and MSI provides prognostic and predictive value. This study aimed to determine OS and progression-free survival (PFS) for metastatic CRC based on these molecular markers with a minimum follow-up of one year.

In the etiology of a large number of metabolic disorders, free radicals are involved in the first line, in particular in the physiopathology of cancers. This interventional study aimed to evaluate in vitro the DPPH radical scavenging activity of a hydroalcoholic extract of Cymbopogon citratus (HAECC) and its antiproliferative activity in human osteosarcoma.

Ida Anna Cappello of the Heart Rhythm Management Centre of the University Hospital Brussels (VUB) has made significant strides in the field of biomedical engineering by developing innovative 3D printed surgical guides for cardiovascular procedures. Her research, conducted in close collaboration with cardiologists and cardiac surgeons, holds the potential to revolutionize surgical accuracy in complex heart surgeries.